| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/29/2009 | CN100518829C Preparing process of kappa-carrageenan for medicine capsule |
| 07/29/2009 | CN100518828C Prolonged release biodegradable microspheres and method for preparing same |
| 07/29/2009 | CN100518827C Controlled release hydrocodone formulations |
| 07/29/2009 | CN100518826C Decoloring method and decoloring agent for quinolone injection |
| 07/29/2009 | CN100518823C Hapten-carrier conjugates and uses thereof |
| 07/29/2009 | CN100518819C Medical components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
| 07/29/2009 | CN100518814C Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into biological environmentat from polymer matrix |
| 07/29/2009 | CN100518748C Emulsion containing plant extract, method for producing said emulsion and for obtaining plant extract |
| 07/29/2009 | CN100518737C Cilostazol solid agent |
| 07/29/2009 | CN100518726C Pharmaceutical solutions of modafinil compounds |
| 07/29/2009 | CN100518718C Preparation of powder agglomerates |
| 07/29/2009 | CA2619367A1 Gel preparation for oral administration |
| 07/28/2009 | US7566770 Humanized collagen antibodies and related methods |
| 07/28/2009 | US7566766 Use of phage display libraries in a screening assay in order to determine the identity of peptides sequences which enhance the delivery of the bacteriophage through tissue, such as epithelial cells lining the lumen of gastrointestinal tract |
| 07/28/2009 | US7566742 phosphoprotein preparation comprises a partially cross-linked partial hydrolysate of casein; a source of calcium ions; and a source of phosphate ions, or a source of strontium ions; calcium phosphate |
| 07/28/2009 | US7566704 anti-infective to combat infection associated with burns, surgery, chemotherapy, bone marrow disorders and other conditions in which the immune system may be compromised; high molecular weight determined by multi-angle laser light scattering (VHMW-glucan) |
| 07/28/2009 | US7566694 Anti-pathogen treatments |
| 07/28/2009 | US7566460 Hand lotion and surgical scrub; alcohol, chlorhexidine salt, and emulsifier |
| 07/28/2009 | US7566445 Canister comprising container closed with metering valve, comprising pharmaceutical suspension aerosol formulation free of surfactant, which consists of salbutamol sulphate, ethanol, and 1,1,1,2-tetrafluoroethane; higher levels of ethanol have beneficial results |
| 07/28/2009 | US7566442 Emulsion; nanoparticles of liquid perfluorocarbon cores coated with lipid/surfactant coupled to integrin specific ligand; 3-({7-[(imidazol-2-ylamino)methyl]-1-methyl-4-oxo(3-hydroquinolyl)}carbonylamino)propanoic Acid adduct with Distearoyl-Glycero-3-Phosphoethanolamine-(PEG)-Maleimide deriv; nonantibody |
| 07/28/2009 | CA2505964C Pharmaceutical compositions and dosage forms of thalidomide |
| 07/28/2009 | CA2435159C A method of preparing a collagen sponge |
| 07/28/2009 | CA2389814C Purified cochineal pigment and process for producing the same |
| 07/28/2009 | CA2370067C Pharmaceutical dosage forms for controlled release producing at least a timed pulse |
| 07/24/2009 | CA2618953A1 Colloidosomes having tunable properties and methods for making colloidosomes having tunable properties |
| 07/23/2009 | WO2009092073A2 Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects |
| 07/23/2009 | WO2009092071A2 Amino acid and peptide pro-drugs of phenolic analgesics and uses thereof |
| 07/23/2009 | WO2009091894A1 Ophthalmic preparations |
| 07/23/2009 | WO2009091622A1 Method to enhance aqueous solubility of poorly soluble actives using methoxypolyethylene glycol |
| 07/23/2009 | WO2009091103A1 Complex of biopolymers and insoluble biomolecules, and manufacturing method thereof |
| 07/23/2009 | WO2009091050A1 Composition for oral application |
| 07/23/2009 | WO2009091040A1 Method for production of (2e,6z,8e)-n-isobutyl-2,6,8-decatrienamide (spilanthol), and foods, beverages, cosmetics and pharmaceutical preparations each comprising the compound |
| 07/23/2009 | WO2009091017A1 Stable pharmaceutical composition |
| 07/23/2009 | WO2009090962A1 Microparticle film composition |
| 07/23/2009 | WO2009090950A1 Chitosan-containing compositions and process for production thereof |
| 07/23/2009 | WO2009090558A2 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| 07/23/2009 | WO2009090495A2 Oil and liquid silicone foamable carriers and formulations |
| 07/23/2009 | WO2009090189A1 Powdered protein compositions and methods of making same |
| 07/23/2009 | WO2009089858A1 COMBINATION OF AN ANTI-EDb FIBRONECTIN ANTIBODY-IL-2 FUSION PROTEIN, AND A MOLECULE BINDING TO B CELLS, B CELL PROGENITORS AND/OR THEIR CANCEROUS COUNTERPART |
| 07/23/2009 | WO2009089845A1 Agent for intra-articular injection |
| 07/23/2009 | WO2009067663A8 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds |
| 07/23/2009 | WO2009059309A3 Furin-cleavable peptide linkers for drug-ligand conjugates |
| 07/23/2009 | WO2009043988A3 Method for producing stable powder compositions |
| 07/23/2009 | WO2009026158A3 Inflammation-regulating compositions and methods |
| 07/23/2009 | WO2008106689A3 Breakthrough pain management |
| 07/23/2009 | WO2008055136A3 Liquid formulations of phospholipase enzyme inhibitors |
| 07/23/2009 | WO2007116409A8 Improved vaccines comprising multimeric hsp60 peptide carriers |
| 07/23/2009 | US20090186984 water soluble; hydrolytically stable linkages; immunogens |
| 07/23/2009 | US20090186945 Abuse-resistant amphetamine prodrugs |
| 07/23/2009 | US20090186944 Prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
| 07/23/2009 | US20090186903 Aripiprazole complex formulation and method |
| 07/23/2009 | US20090186890 Pharmaceutical Formulation of Iressa Comprising a Water-Soluble Cellulose Derivative |
| 07/23/2009 | US20090186883 Stable Aqueous Suspension |
| 07/23/2009 | US20090186828 Abuse-resistant amphetamine prodrugs |
| 07/23/2009 | US20090186825 Abuse-resistant amphetamine prodrugs |
| 07/23/2009 | US20090186807 Zinc-free and low-zinc insulin preparations having improved stability |
| 07/23/2009 | US20090186409 Compositions and methods for the diagnosis and treatment of tumor |
| 07/23/2009 | US20090186147 Transdermal drug delivery devices having coated microprotrusions |
| 07/23/2009 | US20090186096 Applications of microencapsulated essential oils |
| 07/23/2009 | US20090186082 Method of manufacturing modified release dosage forms |
| 07/23/2009 | US20090186081 Disintegrating Loadable Tablets |
| 07/23/2009 | US20090186070 Particle immobilized coating and uses thereof |
| 07/23/2009 | US20090186067 Medical devices having improved mechanical performance |
| 07/23/2009 | US20090186060 Methods of enhancing radiation effects with metal nanoparticles |
| 07/23/2009 | US20090186057 Topical Use of Probiotic Bacillus Spores to Prevent or Control Microbial Infections |
| 07/23/2009 | US20090186036 Anti-Alpha V Beta 6 Antibodies |
| 07/23/2009 | US20090185998 New activated poly(ethylene glycols) and related polymers and their applications |
| 07/23/2009 | US20090185996 Hydroxyethyl starch-containing polypeptide compositions |
| 07/23/2009 | US20090185983 Aqueous medicament preparations for the production of propellant gas-free aerosols |
| 07/23/2009 | DE4418115B4 Galenische Formulierungen Pharmaceutical formulations |
| 07/23/2009 | DE19521753B4 Monomere Insulinanalogonformulierungen Monomeric insulin analog formulations |
| 07/23/2009 | DE102008004893A1 Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung Carrier pellets, processes for their preparation and their use |
| 07/23/2009 | DE102008000084A1 Wässrige Emulsion enthaltend ein Cyclodextrinderivat, einen Riechstoff und ein Polysorbat Aqueous emulsion containing a cyclodextrin derivative, a perfume and a polysorbate |
| 07/23/2009 | CA2787097A1 Low viscosity liquid polymeric delivery system |
| 07/23/2009 | CA2713365A1 Stabilized sustained release composition of bupropion hydrochloride and process for preparing the same |
| 07/23/2009 | CA2712527A1 Chitosan gel for dermatological use, production method and use of same |
| 07/23/2009 | CA2712170A1 Stable pharmaceutical composition |
| 07/23/2009 | CA2712120A1 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| 07/23/2009 | CA2711984A1 Powdered protein compositions and methods of making same |
| 07/23/2009 | CA2711902A1 Combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule binding to b cells, b cell progenitors and/or their cancerous counterpart |
| 07/22/2009 | EP2080804A1 Modified cytokines for use in cancer therapy |
| 07/22/2009 | EP2080779A1 Polymeric derivative of nucleic acid metabolic antagonist |
| 07/22/2009 | EP2080771A2 New interferon beta-like molecules |
| 07/22/2009 | EP2080767A1 Composition for introduction of nucleic acid |
| 07/22/2009 | EP2080526A1 Radioactive diagnostic imaging agent |
| 07/22/2009 | EP2080525A1 Remodeling and Glycoconjugation of Peptides |
| 07/22/2009 | EP2080524A1 Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process |
| 07/22/2009 | EP2080511A2 Active agent delivery systems and methods for protecting and administering active agents |
| 07/22/2009 | EP2080509A1 Lubricious, non-tacky personal lubricant |
| 07/22/2009 | EP2079840A1 Immunotox n fusions comprising an antibody fragment and a plant toxin linked by protease cleavable linkers |
| 07/22/2009 | EP2079529A1 Antimicrobially active composition having a content of bispyridinium alkane (octenidine dihydrochloride) |
| 07/22/2009 | EP2079486A2 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 07/22/2009 | EP2079474A1 Liposome encapsulated poly-iclc method to prophylactically treat an avian influenza viral infection |
| 07/22/2009 | EP2079458A2 Transdermal therapeutic system with two-phase releasing profile |
| 07/22/2009 | EP2079455A1 Pharmaceutical composition comprising a dihydrobenzofuranyl isoindoline and a lipophilic component |
| 07/22/2009 | EP2079449A2 Phenylalkylamino carbamate compositions |
| 07/22/2009 | EP2079447A1 Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers |
| 07/22/2009 | EP2079444A2 Particles for cell targeting |
| 07/22/2009 | EP2005968A9 Nanocomposite particle |
| 07/22/2009 | EP1998784B1 Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing |